AbCellera Biologics's total assets for Q4 2025 were $1.36B, an increase of 0.07% from the previous quarter. ABCL total liabilities were $215.59M for the fiscal quarter, a -45.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.